{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 459955149
| IUPAC_name = 3-(Diethylcarbamoyl)-9,10-dimethoxy-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-yl acetate
| image = Benzquinamide.svg
| width =  
| alt =  
| image2 =  
| width2 =  
| drug_name = 

<!--Clinical data-->
| tradename = Promecon, Quantril, Emete-Con
| licence_EU = <!-- EMA requires brand name -->
| licence_US = Quantril
| DailyMedID = <!-- preference to licence_US -->
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| dependency_liability =  
| routes_of_administration = Suppository, injection
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 63-12-7
| CAS_supplemental =  
| ATCvet =  
| ATC_prefix = none
| ATC_suffix =  
| ATC_supplemental =  
| PubChem =  
| PubChemSubstance =  
| IUPHAR_ligand = 7124
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00767 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 2252
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 0475EA27Q3
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D00243
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201250
| synonyms = 
<!--Chemical data-->
| C=22 | H=32 | N=2 | O=5
| molecular_weight = 404.5 g/mol
| SMILES = CCN(CC)C(=O)C1CN2CCc3cc(OC)c(OC)cc3C2CC1OC(=O)C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = InChI=1S/C22H32N2O5/c1-6-23(7-2)22(26)17-13-24-9-8-15-10-20(27-4)21(28-5)11-16(15)18(24)12-19(17)29-14(3)25/h10-11,17-19H,6-9,12-13H2,1-5H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = JSZILQVIPPROJI-UHFFFAOYSA-N
| density =  
| melting_point =  
| melting_high =  
| melting_notes =  
| boiling_point =  
| boiling_notes =  
| solubility =  
| specific_rotation =  
| sec_combustion =  
}}

'''Benzquinamide''' is a discontinued [[antiemetic]] drug used in [[post-operative]] care. It was first synthesised by [[Pfizer]] in the 1960s.<ref name="Scriabine1963">{{cite journal|vauthors = Scriabine A, Weissman A, Finger KF|title=Benzquinamide|journal=JAMA|volume=184|issue=4|year=1963|pages=276|issn=0098-7484|doi=10.1001/jama.1963.73700170001010}}</ref>
<ref>{{cite journal | author = E.I. Goldenthal | journal = Toxicol. Appl. Pharmacol. | volume = 18 | pages = 185â€“207 | year = 1971 | doi = 10.1016/0041-008X(71)90328-0 | pmid = 5542824 | title = A compilation of LD50 values in newborn and adult animals | issue = 1}}</ref>

==References==
{{reflist}}

[[Category:Antiemetics]]
[[Category:Antipsychotics]]
[[Category:Acetate esters]]


{{gastrointestinal-drug-stub}}